Results 21 to 30 of about 30,032,344 (197)

Coexistence of neurofibromatosis type-1 and primary pulmonary sarcoma: a case report and review of the literature [PDF]

, 2014
Neurofibromatosis type-1 (NF1) is a genetic disorder characterized by café-au-lait spots, neurofibroma and other associated features. The risk of malignancy is approximately 2.5 to 4-fold higher as compared to general population.
Lim, Suat Yee, Chin, Pek Woon, Md Tarekh, Noor Aliza, Hoo, Fan Kee, Boo, Yang Liang   +4 more
core   +1 more source

Guidelines for the Multidisciplinary Diagnosis and Treatment of Neurofibromatosis Type 1(2023 Version)

罕见病研究, 2023
Neurofibromatosis type 1(NF1) is an autosomal dominant hereditary neoplastic disease caused by mutations in the NF1 gene. Features of disorder typically appear in early childhood.
Multidisciplinary Diagnosis and Treatment Collaboration Group for Neurofibromatosis Type 1 of China Alliance for Rare Diseases
doaj   +1 more source

MITIGATING HIGH-RISK COMPLICATIONS: TENSION HEMOTHORAX IN NF-1 PATIENTS UNDERGOING SCOLIOSIS CORRECTION [PDF]

Coluna/Columna
Objectives: This study aims to report and analyze two cases of tension hemothorax in patients with neurofibromatosis type 1 (NF1) undergoing scoliosis surgery, highlighting the incidence, etiology, and optimal treatment strategies.
OLGA SERGEENKO, ANASTACIA GABRIELYAN, DMITRY SAVIN, POLINA OCHIROVA, ALEXANDER BURTSEV, ALEXEY EVSYUKOV   +5 more
doaj   +1 more source

Neurofibromatosis type 1 (NF1) [PDF]

, 1997
Review on Neurofibromatosis type 1 (NF1), with data on clinics, and the genes ...
Huret, JL
core   +1 more source

Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine

Cell Death and Disease, 2021
Neurofibromatosis type 1 is an autosomal dominant genetic disorder caused by mutation in the neurofibromin 1 (NF1) gene. Its hallmarks are cutaneous findings including neurofibromas, benign peripheral nerve sheath tumors.
Gaku Tsuji, Ayako Takai-Yumine, Takahiro Kato, Masutaka Furue   +3 more
doaj   +1 more source

Metabolic Alterations in Macrophage Subtypes Propel Immune and Stromal Remodeling in Neurofibroma's Malignant Progression

MedComm
Neurofibromatosis type 1 (NF1) is characterized by the development of benign plexiform neurofibromas (PNFs). In 10%–15% of patients, these tumors undergo malignant transformation into aggressive malignant peripheral nerve sheath tumors (MPNSTs).
Ling‐Ling Ge, Yue‐Hua Li, Xuan Yu, Ming‐Yan Xing, Yi‐Hui Gu, Wei Wang, Jing‐Xuan Huang, Jun Liu, Hai‐Bing Zhang, Cheng‐Jiang Wei, Zhi‐Chao Wang, Qing‐Feng Li   +11 more
doaj   +1 more source

Malignant peripheral nerve sheath tumor of the cervical vagus nerve in a neurofibromatosis type 1 patient - An unusual presentation [PDF]

, 2010
Malignant peripheral nerve sheath tumors (MPNST’S) of the head and neck comprise 2% to 6% of head and neck sarcomas. These tumors may arise as sporadic variants or in patients with neurofibromatosis (NF).
Amanjit Bahl, Gupta, A, Sandeep Bansal, Sanjeev Bhagat, Ashok Gupta, Bahl, A, Bansal, S, Bhagat, S   +7 more
core  

Neurofibromatosis type 1 (NF1) [PDF]

, 2006
Review on Neurofibromatosis type 1 (NF1), with data on clinics, and the genes ...
Wimmer, K
core   +1 more source

Central Nervous System Tumors Among Infants in Canada: A Report From CYP‐C

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Central nervous system (CNS) tumors in infants are rare, pose unique clinical challenges, and lack large‐scale evidence‐based data to guide management. This study seeks to describe CNS tumors in Canadian infants and to compare their outcomes with those of older children.
Samuel Sassine, Hallie Coltin, Sylvia Cheng, Lucie Lafay‐Cousin, Vanan Issai Magimairajan, Craig Erker, Stéphanie Vairy, Lynette Bowes, Adam Fleming, Donna Johnston, Sarah McKillop, Roona Sinha, Julie Bennett, Christina Coleman, Laura Wheaton, Shayna Zelcer, Samuele Renzi, Thai Hoa Tran   +17 more
wiley   +1 more source

Identification of growth hormone receptor in plexiform neurofibromas of patients with neurofibromatosis type 1

Clinics, 2008
OBJECTIVE: The aim of this study was to investigate the presence of growth hormone receptor in plexiform neurofibromas of neurofibromatosis type 1 patients.
Karin Soares Gonçalves Cunha, Eliane Porto Barboza, Eliene Carvalho da Fonseca   +2 more
doaj   +1 more source